Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Abraham

Showing results (31-40 of 257) with videos related to

Pageof 26
Sort By:
Clinics in Chest Medicine|January 9, 2004
New approaches to the treatment of sepsisJames M O'Brien, Edward Abraham
American Journal of Respiratory and Critical Care Medicine|January 27, 2006
Beta-adrenergic agonist therapy as a potential treatment for acute lung injuryMichael A Matthay, Edward Abraham
American Journal of Respiratory and Critical Care Medicine|July 28, 2009
Changes in NIH review procedures: strengths and weaknessesKenneth B Adler, Edward Abraham
American Journal of Respiratory and Critical Care Medicine|August 30, 2008
When is a negative phase II trial truly negative?Gordon D Rubenfeld, Edward Abraham
American Journal of Respiratory Cell and Molecular Biology|July 22, 2009
Changes in NIH review procedures: strengths and weaknessesKenneth B Adler, Edward Abraham
American Journal of Respiratory and Critical Care Medicine|October 22, 2005
The last 100 years of sepsisJean-Louis Vincent, Edward Abraham
American Journal of Respiratory and Critical Care Medicine|October 31, 2002
Does blocking cytokines in sepsis work?Charles A Dinarello, Edward Abraham
Critical Care Medicine|May 1, 2004
Human models of endotoxemia and recombinant human activated protein CJames M O'Brien, Edward Abraham
American Journal of Respiratory and Critical Care Medicine|November 23, 2005
Intensive insulin therapy in critical illnessDerek C Angus, Edward Abraham
Intensive Care Medicine|August 7, 2010
Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine?Emmanuel Lorne, Hervé Dupont, Edward Abraham
Pageof 26

Showing results (31-40 of 257) with videos related to

Sort By:
Pageof 26
Clinics in Chest Medicine|January 9, 2004
New approaches to the treatment of sepsisJames M O'Brien, Edward Abraham
American Journal of Respiratory and Critical Care Medicine|January 27, 2006
Beta-adrenergic agonist therapy as a potential treatment for acute lung injuryMichael A Matthay, Edward Abraham
American Journal of Respiratory and Critical Care Medicine|July 28, 2009
Changes in NIH review procedures: strengths and weaknessesKenneth B Adler, Edward Abraham
American Journal of Respiratory and Critical Care Medicine|August 30, 2008
When is a negative phase II trial truly negative?Gordon D Rubenfeld, Edward Abraham
American Journal of Respiratory Cell and Molecular Biology|July 22, 2009
Changes in NIH review procedures: strengths and weaknessesKenneth B Adler, Edward Abraham
American Journal of Respiratory and Critical Care Medicine|October 22, 2005
The last 100 years of sepsisJean-Louis Vincent, Edward Abraham
American Journal of Respiratory and Critical Care Medicine|October 31, 2002
Does blocking cytokines in sepsis work?Charles A Dinarello, Edward Abraham
Critical Care Medicine|May 1, 2004
Human models of endotoxemia and recombinant human activated protein CJames M O'Brien, Edward Abraham
American Journal of Respiratory and Critical Care Medicine|November 23, 2005
Intensive insulin therapy in critical illnessDerek C Angus, Edward Abraham
Intensive Care Medicine|August 7, 2010
Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine?Emmanuel Lorne, Hervé Dupont, Edward Abraham
Pageof 26